Document is current
Any future updates will be listed below
-
Authors
Holec, Miroslav
Gozes, Illana
- License Information
-
More Information
Article History
First Online: 24 April 2025
Declarations
:
: All information was obtained with parental (caregiver) informed consent.
: The use of davunetide is under patent protection. Professor Illana Gozes serves as Vice President Drug Development, ExoNavis Therapeutics Ltd, and Editor-in-Chief, Journal of Molecular Neuroscience.
Free to read: This content has been made available to all.
